HSA Approval

MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG

Approval Number

SIN14954P

Drug Name

Product Name

MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG

Approval Date

February 19, 2016

Registrant

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Licence Holder

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

Registrant

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Licence Holder

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, CHEWABLE

Route of Administration

ORAL

Medical Information

ATC Code

R03DC03

ATC Item Name

montelukast

Manufacturer Information

Pharmaceutical Manufacturer

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Manufacturers

Hetero Labs Limited

Active Ingredients

Ingredient Name

Montelukast Sodium 4.160 mg eqv Montelukast

Strength

4.000 mg

Drug MonographMontelukast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG - HSA Approval | MedPath

AI-Powered Research

Premium Access

MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal